B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin

類似資料

• B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence
  著者:: Daoussis, Dimitrios, 等
  出版事項: (2011)
• B cell depletion therapy upregulates Dkk-1 skin expression in patients with systemic sclerosis: association with enhanced resolution of skin fibrosis
  著者:: Daoussis, Dimitrios, 等
  出版事項: (2016)
• Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
  著者:: Daoussis, Dimitrios, 等
  出版事項: (2010)
• Treatment of systemic sclerosis associated fibrotic manifestations: Current options and future directions
  著者:: Daoussis, Dimitrios, 等
  出版事項: (2019)
• B Cell Depletion Treatment in Resistant Systemic Sclerosis Interstitial Lung Disease
  著者:: Constantina A. Bounia, 等
  出版事項: (2019-01-01)